Provided by Tiger Trade Technology Pte. Ltd.

RxSIGHT, INC.

4.95
-0.0500-1.00%
Post-market: 4.950.00000.00%16:10 EDT
Volume:646.52K
Turnover:3.20M
Market Cap:204.91M
PE:-4.36
High:5.03
Open:5.00
Low:4.91
Close:5.00
52wk High:16.00
52wk Low:4.70
Shares:41.40M
Float Shares:32.44M
Volume Ratio:0.57
T/O Rate:1.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1361
EPS(LYR):-0.9533
ROE:-17.06%
ROA:-11.21%
PB:0.77
PE(LYR):-5.19

Loading ...

RxSight Securities Lawsuit Advances After Court Denies Dismissal Bid

TIPRANKS
·
May 30

Analysts Conflicted on These Healthcare Names: RxSight (RXST), Liquidia Technologies (LQDA) and Krystal Biotech (KRYS)

TIPRANKS
·
May 14

RxSight Earnings Call Balances Growth With Headwinds

TIPRANKS
·
May 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Voyager Therapeutics (VYGR), Alpha Teknova (TKNO) and RxSight (RXST)

TIPRANKS
·
May 09

RxSight price target lowered to $11 from $13 at Needham

TIPRANKS
·
May 07

Needham Cuts Price Target on RxSight to $11 From $13, Keeps Buy Rating

MT Newswires Live
·
May 07

RxSight Is Maintained at Buy by Needham

Dow Jones
·
May 07

Rxsight Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

RxSight Q1 revenue beats estimates

Reuters
·
May 07

RxSight Q1 net loss widens to $(15.9) million; sales fall 18.5% to $30.9 million

Reuters
·
May 07

RxSight Q1 Adj. EPS $(0.19) Beats $(0.28) Estimate, Sales $30.893M Beat $29.744M Estimate

Benzinga
·
May 07

BRIEF-Rxsight Q1 Revenue USD 30.9 Million Vs. IBES Estimate USD 29.7 Million

Reuters
·
May 07

Rxsight Q1 Adjusted EPS USD -0.19 VS. Ibes Estimate USD -0.28

THOMSON REUTERS
·
May 07

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

GlobeNewswire
·
May 07

Rxsight Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
May 05

RxSight announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 29

RxSight to report first-quarter results after market close May 6

Reuters
·
Apr 23

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

GlobeNewswire
·
Apr 23

RxSight highlights ASCRS data showing 91.2% LAL accuracy within 0.50 diopters

Reuters
·
Apr 09

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

GlobeNewswire
·
Apr 09